Inventor · disambiguated record
Annie Bouchard
Also filed as: BOUCHARD ANNIE
10 granted patents·5 pending applications·70 citations·filing 2014–2022
87Inventor score
Files withSIGNPATH PHARMA INC15
Top patents by PatentIndex Score
15 records- 0196US10449193B2Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathiesSIGNPATH PHARMA INC·Filed 2016·Granted Oct 22, 2019·13 cites·18 claims
- 0296US10238602B2Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathiesSIGNPATH PHARMA INC·Filed 2017·Granted Mar 26, 2019·16 cites·7 claims
- 0395US10349884B2Liposomal mitigation of drug-induced inhibition of the cardiac ikr channelSIGNPATH PHARMA INC·Filed 2017·Granted Jul 16, 2019·16 cites·20 claims
- 0492US10258691B2Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathiesSIGNPATH PHARMA INC·Filed 2015·Granted Apr 16, 2019·16 cites·10 claims
- 0583US10532045B2Liposomal mitigation of drug-induced inhibition of the cardiac IKr channelSIGNPATH PHARMA INC·Filed 2014·Granted Jan 14, 2020·6 cites·13 claims
- 0680US10975111B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2019·Granted Apr 13, 2021·3 cites·16 claims
- 0775US11746119B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2021·Granted Sep 5, 2023·0 cites·12 claims
- 0866US11643424B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2021·Granted May 9, 2023·0 cites·14 claims
- 0965US2019388422A1Protective effect of dmpc, dmpg, dmpc/dmpg, lysopg and lysopc against drugs that cause channelopathiesSIGNPATH PHARMA INC·Filed 2019·Application pending·0 cites
- 1064US2020108056A1Liposomal Mitigation of Drug-Induced Inhibition of the Cardiac IKR ChannelSIGNPATH PHARMA INC·Filed 2019·Application pending·0 cites
- 1163US2019167585A1Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause ChannelopathiesSIGNPATH PHARMA INC·Filed 2019·Application pending·0 cites
- 1258US2023042703A1Cardioprotective Lipid and Method of UseSIGNPATH PHARMA INC·Filed 2022·Application pending·0 cites
- 1348US12004868B2Liposomal mitigation of drug-induced inhibition of the cardiac IKr channelSIGNPATH PHARMA INC·Filed 2019·Granted Jun 11, 2024·0 cites·10 claims
- 1448US11806401B2Prevention of drug-induced atrio-ventricular blockSIGNPATH PHARMA INC·Filed 2017·Granted Nov 7, 2023·0 cites·5 claims
- 1548US2019008878A1Compositions and method for reducing cardiotoxicitySIGNPATH PHARMA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annie Bouchard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →